Author of the article:
Canadian Press
Apotex Pharmaceutical Holdings Inc. — the generic drug company founded by murdered Canadian billionaire Barry Sherman — has signed a deal to be acquired by U.S. private equity investment firm SK Capital Partners.
Financial terms of the agreement for the Canadian drug company were not immediately available.
From our newsroom to your inbox at noon, the latest headlines, stories, opinion and photos from the Toronto Sun.
Thanks for signing up!
A welcome email is on its way. If you don't see it, please check your junk folder.
The next issue of Your Midday Sun will soon be in your inbox.
Aaron Davenport, managing director at SK Capital, says Apotex is a dynamic, entrepreneurial company with a strong track record of success, underpinned by its diversified product portfolio, robust pipeline of new launches and iconic brand.
Apotex employs nearly 8,000 people around the world in manufacturing, research and development and commercial operations.
Sherman founded the company in 1974.
It operates in more than 45 countries, with a significant presence in Canada, the United States, Mexico and India.
The deal is subject to customary regulatory conditions.
Sherman and his wife, Honey, were found dead inside their Toronto home on Dec. 15, 2017.
No arrests have been made.